The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
President Donald Trump has issued a stringent warning to pharmaceutical companies, advising them to repatriate their ...
Novo Nordisk (NVO) CEO Lars Jørgensen isn't too worried about the upcoming Medicare price negotiations over blockbuster GLP-1 drugs, even though the company still stands with the industry against ...
Novo Nordisk faces challenges but its pipeline remains strong. Find out why NVO stock could deliver high double-digit returns ...
The Centers for Medicare & Medicaid Services reported ... beating its benchmark by 150 percentage points (see more details here). Novo Nordisk A/S (NYSE:NVO) is a global healthcare company ...
5h
Axios on MSNCopycat Ozempic makers brace for crackdownMakers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results